Early clinical experience and impact of 18F-FDG PET.

Keyphrases

• Clinical Impact 100%
• Early Clinical Exposure 100%
• Patient Management 50%
• Oncology 33%
• Referring Physician 33%
• F-fluorodeoxyglucose Positron Emission Tomography 16%
• Radiation Therapy 16%
• Nervous System Neoplasms 16%
• Treatment Plan 16%
• Impact on Patients 16%
• Primary Diagnosis 16%
• General Satisfaction 16%
• Digestive System 16%
• Unknown Primary Neoplasms 16%
• Melanoma 16%

Medicine and Dentistry

• Fluorodeoxyglucose 87%
• Oncology 25%
• Cancer of Unknown Primary Origin 12%
• Digestive System 12%
• Nervous System Tumor 12%
• Neurology 12%